ArticlePLOS global public health2025
Opportunistic random blood glucose screening among professional drivers in northeastern Bangladesh: Assessing undiagnosed diabetes and health awareness.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes remains a silent epidemic in underrepresented high-risk groups like professional drivers, highlighting the urgent need for informed health policies and targeted interventions. This study aimed to assess the prevalence of undiagnosed diabetes and related health awareness among professional drivers in northeastern Bangladesh using opportunistic random blood glucose (RBG) testing to address knowledge gaps and inform health policy. A cross-sectional study was conducted on 1,454 participants enrolled between February 5, 2024 and July 27, 2024, using a consent-based questionnaire, anthropometric measurements, and RBG testing with a glucometer. Diabetes awareness was assessed using pre-tested questionnaires, while the prevalence of diabetes and associated factors were evaluated using Mann-Whitney U tests, Welch ANOVA, and Spearman correlation analysis. A total of 2.20% of the driver population were found to have undiagnosed diabetes. RBG levels differed significantly across regions. Middle age (7.63%) and overweight (3.77%) groups exhibited the highest prevalence of undiagnosed diabetes. Confounding variables such as BMI (r = 0.22, p < 0.0001), age (r = 0.19, p < 0.0001), and sleep duration (r = -0.05, p = 0.04) were significantly associated with glucose levels, indicating potential risk factors for diabetes. The obese group (AOR: 3.04, 95% CI: 0.81-11.46) and overweight group (AOR: 1.81, 95% CI: 0.83-3.99) were 3.04 and 1.81 times more likely, respectively, to develop diabetes compared to the healthy weight group. Participants with less than 7 hours of sleep (AOR: 1.13, 95% CI: 0.46-2.75) were also at greater risk. Co-morbidities and a family history of diabetes were also significantly associated with elevated RBG levels. Overall, this study highlights the regional and behavioral disparities influencing the development of diabetes risk among professional drivers, a population often neglected in health policy. It underscores the need for health education and large-scale RBG testing to improve awareness and alert policymakers in formulating effective health guidelines.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.